Dr Anthony Burgos, MD - Medicare Diagnostic Radiology in Hamilton, NJ

Dr Anthony Burgos, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Hamilton, New Jersey. He went to Rutgers R W Johnson Medical School (cam/new Bruns/pisc) and graduated in 2003 and has 21 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Imaging Group Of Delaware Pa, Radiology Affiliates Of Central New Jersey P C, Imaging Group Of Delaware Pa, Radiology Affiliates Of Central New Jersey P C, Imaging Group Of Delaware Pa and his current practice location is 2501 Kuser Rd, Hamilton, New Jersey. You can reach out to his office (for appointments etc.) via phone at (609) 585-8800.

Dr Anthony Burgos is licensed to practice in New Jersey (license number 25MA07845400) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1376702258.

Contact Information

Dr Anthony Burgos, MD
2501 Kuser Rd,
Hamilton, NJ 08691-3386
(609) 585-8800
Not Available



Physician's Profile

Full NameDr Anthony Burgos
GenderMale
SpecialityDiagnostic Radiology
Experience21 Years
Location2501 Kuser Rd, Hamilton, New Jersey
Accepts Medicare AssignmentsMay be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Anthony Burgos attended and graduated from Rutgers R W Johnson Medical School (cam/new Bruns/pisc) in 2003
  NPI Data:
  • NPI Number: 1376702258
  • Provider Enumeration Date: 06/05/2008
  • Last Update Date: 08/26/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 1850445669
  • Enrollment ID: I20090813000278

Medical Identifiers

Medical identifiers for Dr Anthony Burgos such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1376702258NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 25MA07845400 (New Jersey)Secondary
2085R0202XRadiology - Diagnostic Radiology MD436906 (Pennsylvania)Secondary
2085R0204XRadiology - Vascular & Interventional Radiology 25MA07845400 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Robert Wood Johnson University Hospital At HamiltonHamilton, NJHospital
St Mary Medical CenterLanghorne, PAHospital
Holy Redeemer Hospital And Medical CenterMeadowbrook, PAHospital
Nazareth HospitalPhiladelphia, PAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Imaging Group Of Delaware Pa054715247233
Radiology Affiliates Of Central New Jersey P C175927723964
Imaging Group Of Delaware Pa054715247233
Radiology Affiliates Of Central New Jersey P C175927723964
Imaging Group Of Delaware Pa054715247233

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anthony Burgos allows following entities to bill medicare on his behalf.
Entity NameGeisinger Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366493868
PECOS PAC ID: 5395657001
Enrollment ID: O20040130000518

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Entity NameRadiology Affiliates Of Central New Jersey P C
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811994791
PECOS PAC ID: 1759277239
Enrollment ID: O20040223000732

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Entity NameUniversity Of Pittsburgh Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619935004
PECOS PAC ID: 8729990239
Enrollment ID: O20040308000883

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Entity NameHr Physician Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881696698
PECOS PAC ID: 0042109902
Enrollment ID: O20040311000028

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Entity NameImaging Group Of Delaware Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164421574
PECOS PAC ID: 0547152472
Enrollment ID: O20170511000263

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anthony Burgos is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Anthony Burgos, MD
2501 Kuser Rd,
Hamilton, NJ 08691-3386

Ph: (609) 585-8800
Dr Anthony Burgos, MD
2501 Kuser Rd,
Hamilton, NJ 08691-3386

Ph: (609) 585-8800

News Archive

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

BioSante enrolls 2,500th woman in LibiGel Phase III cardiovascular and breast cancer safety study

BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.

MGH researchers discover regulators of gene expression programs in medulloblastoma

Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. In their report published online in Cancer Discovery, the team also identifies potential targets for future treatments.

Itch-specific nerve cells in skin discovered by John Hopkins scientists

Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.

Read more News

› Verified 5 days ago


Radiology Doctors in Hamilton, NJ

Steven L Meshkov, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825
Joseph J. Kim, MD
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825
Gustavo Sanchez, MD
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825
Roy M Prager, M.D.
Radiology
Medicare: Medicare Enrolled
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825
Dr. Jeffrey John Mathews, M.D.
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    
Richard F. Scafidi, MD
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 2501 Kuser Rd, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825
Paul J. Weiser, MD
Radiology
Medicare: May Accept Medicare Assignments
Practice Location: 2501 Kuser Rd, Ste 514, Hamilton, NJ 08691
Phone: 609-585-8800    Fax: 609-585-1825

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.